Tumor volume score (TVS), modified recist, and tissue damage score (TDS) as novel methods for assessing response in tenosynovial giant cell tumors (TGCT) treated with pexidartinib: Relationship with patient-reported outcomes (PROs).

Charles Peterfy,Xin Ye,Heather L. Gelhorn,Rebecca M. Speck,Peter Countryman,Vicki L. Keedy,Zev A. Wainberg,Arun S. Singh,Bartosz Chmielowski,Daniel D. Von Hoff,Hani M. Babiker,Vivek Khemka,Gregory M. Cote,Geoffrey I. Shapiro,Andrew J. Wagner,John H. Healey,Henry Hsu,Paul S. Lin,Sandra Tong,William D. Tap

Tumor volume score (TVS), modified recist, and tissue damage score (TDS) as novel methods for assessing response in tenosynovial giant cell tumors (TGCT) treated with pexidartinib: Relationship with patient-reported outcomes (PROs).

2017

11048Background: TGCT is a locally aggressive neoplasm of joint and tendon sheath synovia that may cause pain, limit joint function and destroy bone and local tissues. Measuring TGCT with RECIST is...

Keywords:

Giant Cell Tumors
Pexidartinib
Radiology
Pathology
Medicine
Tendon sheath
tissue damage
Neoplasm
modified recist

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations